115 related articles for article (PubMed ID: 2677632)
1. [Treatment of low malignancy non-Hodgkin lymphomas with recombinant interferon. Current status].
Neubauer A; Herrmann R
Med Klin (Munich); 1989 Jul; 84(7):355-8. PubMed ID: 2677632
[No Abstract] [Full Text] [Related]
2. The role of interferon in the therapy of low grade lymphoma.
McLaughlin P
Leuk Lymphoma; 1993; 10 Suppl():17-20. PubMed ID: 8481666
[No Abstract] [Full Text] [Related]
3. Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group.
Tirelli U
Leukemia; 1991; 5 Suppl 1():105-6. PubMed ID: 1890859
[No Abstract] [Full Text] [Related]
4. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.
Kuzel TM; Gilyon K; Springer E; Variakojis D; Kaul K; Bunn PA; Evans L; Roenigk HH; Rosen ST
J Natl Cancer Inst; 1990 Feb; 82(3):203-7. PubMed ID: 2296050
[TBL] [Abstract][Full Text] [Related]
5. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma.
Steis RG; Foon KA; Longo DL
Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466
[TBL] [Abstract][Full Text] [Related]
6. [Therapy with alpha-interferon in non-Hodgkin's lymphoma with a low grade of malignancy (correct title supplied from Table of Contents)].
Chisesi T
Haematologica; 1990; 75 Suppl 4():72-7. PubMed ID: 2074057
[No Abstract] [Full Text] [Related]
7. Alpha-interferon in the treatment of nodular lymphomas.
Urba WJ; Longo DL
Semin Oncol; 1986 Dec; 13(4 Suppl 5):40-7. PubMed ID: 3541218
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials referral resource. Non-Hodgkin's lymphoma.
Cheson BD
Oncology (Williston Park); 1989 Oct; 3(10):37-40, 45-50. PubMed ID: 2640585
[No Abstract] [Full Text] [Related]
9. Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
Scarffe JH; Wagstaff J; Crowther D
Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285
[No Abstract] [Full Text] [Related]
10. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
[TBL] [Abstract][Full Text] [Related]
11. [Clinical aspects and treatment of recurrences of lymphosarcoma in children].
Tselousova OM; Kiselev AV
Pediatriia; 1991; (11):87-90. PubMed ID: 1766751
[TBL] [Abstract][Full Text] [Related]
12. Recombinant alpha interferons 1986: a review.
Lindquist DL; Burns CP
Iowa Med; 1987 Jan; 77(1):32, 34, 36. PubMed ID: 3818250
[No Abstract] [Full Text] [Related]
13. Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
Rohatiner AZ; Richards MA; Barnett MJ; Stansfeld AG; Lister TA
Br J Cancer; 1987 Feb; 55(2):225-6. PubMed ID: 3814493
[No Abstract] [Full Text] [Related]
14. [Optimized therapy. Greater rate of effectiveness with consensus interferon].
MMW Fortschr Med; 2001 Jun; 143(23):40-1. PubMed ID: 11460419
[No Abstract] [Full Text] [Related]
15. Interferons in the management of multiple myeloma.
Cooper MR
Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
[No Abstract] [Full Text] [Related]
16. CML: new biologic therapies, endpoints and questions.
Martin A; Cheson BD
Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
[No Abstract] [Full Text] [Related]
17. Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Krigel RL; Slywotzky CM; Lonberg M; Green MD; Andes WA; Kempf R; Gupta S; Grace W; Spiegel RJ; Muggia FM
J Biol Response Mod; 1988 Aug; 7(4):359-64. PubMed ID: 3049944
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-alpha therapy in non-Hodgkin's lymphoma].
Fridrik MA
Wien Med Wochenschr; 1993; 143(16-17):429-34. PubMed ID: 8273367
[TBL] [Abstract][Full Text] [Related]
19. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy].
Hiddemann W
Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262
[TBL] [Abstract][Full Text] [Related]
20. [Presentation of a randomized multicenter study protocol. "Evaluation of adjuvant interferon effectiveness after radical nephrectomy in kidney carcinoma with high risk of relapse"].
Arch Ital Urol Nefrol Androl; 1990 Mar; 62(1):177-83. PubMed ID: 2141713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
